ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives:

1. - Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control.

2. - Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tennessee Medical Center
• Treatments: Dexamethasone; Ropivacaine

Criteria

Inclusion Criteria:

• Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM.

• Female participants of childbearing potential will be required to provide a negative pregnancy test.

• Ability to understand and teach back consent for the procedure.

• Willingness to sign consent for procedure.

• English speaking.

Exclusion Criteria:

• Emergent surgery status.

• Local infection

• Allergy to local anesthetics.

• Recreational drug use.

• Inability to provide informed consent.

• Pregnancy or breastfeeding.

• History of Guillain-Barre' Syndrome.

• Underlying medical conditions that would post a significant risk to the patient.

• Opioid use >90 days in the year leading up to surgery.